N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18:1(4E))(2-)

Term ID

CHEBI:230468

Synonyms

a ganglioside Ac-O-9-GD2(d18:1(4E))
beta-D-GalNac-(1->4)-(alpha-N-Neu5,9Ac2-(2->8)-alpha-N-NeuAc-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer(d18:1(4E))(2-)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(2-)

N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(2-) Show first 5 Terms

Phenotype

Phenotype resulting from N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18:1(4E))(2-)

Phenotype where environments contain N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18:1(4E))(2-)

Phenotype modified by environments containing N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-N-acetyl-9-O-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide(d18:1(4E))(2-)

Human Disease Model